Mattingly J, Wu A, York A
Immune Netw. 2025; 25(1):e11.
PMID: 40078786
PMC: 11896658.
DOI: 10.4110/in.2025.25.e11.
Kennewick K, Bensinger S
Nat Metab. 2025; .
PMID: 40065101
DOI: 10.1038/s42255-025-01240-x.
Huang X, Liu B, Shen S
Cancers (Basel). 2025; 17(4).
PMID: 40002245
PMC: 11852908.
DOI: 10.3390/cancers17040650.
Du L, Cui Y, Zhou Y, Kwaku O, Ding X, Zeng L
Hereditas. 2025; 162(1):22.
PMID: 39953634
PMC: 11827142.
DOI: 10.1186/s41065-025-00388-6.
Chang K, Luo P, Guo Z, Yang L, Pu J, Han F
Clin Rev Allergy Immunol. 2025; 68(1):15.
PMID: 39934534
PMC: 11813826.
DOI: 10.1007/s12016-025-09023-8.
Lipid metabolism in myeloid cell function and chronic inflammatory diseases.
Ito A, Suganami T
Front Immunol. 2025; 15:1495853.
PMID: 39911578
PMC: 11794072.
DOI: 10.3389/fimmu.2024.1495853.
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.
Scalambra L, Ruzzi F, Pittino O, Semprini M, Cappello C, Angelicola S
J Transl Med. 2025; 23(1):136.
PMID: 39885551
PMC: 11784117.
DOI: 10.1186/s12967-025-06126-w.
tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells.
Miao S, Li H, Song X, Liu Y, Wang G, Kan C
J Exp Med. 2025; 222(3).
PMID: 39873720
PMC: 11774205.
DOI: 10.1084/jem.20240559.
Lipid metabolism in tumor-infiltrating T cells: mechanisms and applications.
Ke X, Zou M, Xu C
Life Metab. 2025; 1(3):211-223.
PMID: 39872079
PMC: 11749778.
DOI: 10.1093/lifemeta/loac038.
PCSK9 in T-cell function and the immune response.
Wang Y, Fang X, Liu J, Lv X, Lu K, Lu Y
Biomark Res. 2024; 12(1):163.
PMID: 39736777
PMC: 11687167.
DOI: 10.1186/s40364-024-00712-8.
Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation.
Jacobs B, Gasperi C, Kalluri S, Al-Najjar R, McKeon M, Else J
Cell Rep Med. 2024; 6(1):101733.
PMID: 39708811
PMC: 11866449.
DOI: 10.1016/j.xcrm.2024.101733.
Cholesterol: The driving force behind the remodeling of tumor microenvironment in colorectal cancer.
Wang K, Zhang Y, Si C, Cao Y, Shao P, Zhang P
Heliyon. 2024; 10(23):e39425.
PMID: 39687190
PMC: 11648115.
DOI: 10.1016/j.heliyon.2024.e39425.
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy.
Zhang H, Li Y, Huang J, Shen L, Xiong Y
Acta Pharm Sin B. 2024; 14(11):4717-4737.
PMID: 39664426
PMC: 11628863.
DOI: 10.1016/j.apsb.2024.07.021.
Cholesterol sensing and metabolic adaptation in tissue immunity.
Dang E, Reboldi A
Trends Immunol. 2024; 45(11):861-870.
PMID: 39424470
PMC: 11560508.
DOI: 10.1016/j.it.2024.09.013.
Regulation of CD8+ T cells by lipid metabolism in cancer progression.
Tang Y, Chen Z, Zuo Q, Kang Y
Cell Mol Immunol. 2024; 21(11):1215-1230.
PMID: 39402302
PMC: 11527989.
DOI: 10.1038/s41423-024-01224-z.
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.
Hu T, Liu C, Lei M, Zeng Q, Li L, Tang H
Signal Transduct Target Ther. 2024; 9(1):268.
PMID: 39379377
PMC: 11461632.
DOI: 10.1038/s41392-024-01954-6.
Cholesterol promotes mRNA expression in CD4 effector/memory cells by SGK1 activation.
Hanin A, Comi M, Sumida T, Hafler D
Life Sci Alliance. 2024; 7(12).
PMID: 39366761
PMC: 11452476.
DOI: 10.26508/lsa.202402890.
Focusing on CD8 T-cell phenotypes: improving solid tumor therapy.
Yao Z, Zeng Y, Liu C, Jin H, Wang H, Zhang Y
J Exp Clin Cancer Res. 2024; 43(1):266.
PMID: 39342365
PMC: 11437975.
DOI: 10.1186/s13046-024-03195-5.
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.
Fiorenza S, Zheng Y, Purushe J, Bock T, Sarthy J, Janssens D
Nat Commun. 2024; 15(1):8309.
PMID: 39333103
PMC: 11436946.
DOI: 10.1038/s41467-024-52503-2.
Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis.
Bonacina F, Zhang X, Manel N, Yvan-Charvet L, Razani B, Norata G
Nat Rev Cardiol. 2024; 22(3):149-164.
PMID: 39304748
PMC: 11835540.
DOI: 10.1038/s41569-024-01072-4.